跳至主要内容
临床试验/NCT04699292
NCT04699292招募中不适用

International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas

The Netherlands Cancer Institute1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
Local recurrence free survival

研究概览

简要总结

To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)

详细描述

In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Biopsy proven MLS, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
  • ECOG PS 0-2
  • Written informed consent to share coded information in this international Registry

排除标准

  • Prior radiotherapy to the target area
  • Pregnancy

结局指标

主要结局

Local recurrence free survival

时间窗: From surgery to the end of at least 5 years of follow-up

Survival from surgery to local recurrence (event) or last follow-up

次要结局

  • Wound complications(From surgery to 6 months of follow-up)
  • Late toxicity(From 3 months after surgery to the end of at least 5 years of follow-up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验